Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02703532 · ClinicalTrials.gov registry record · NA

Evaluation of a CarePartner-Integrated Telehealth Rehabilitation Program for Persons With Stroke

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
64
Enrollment target

NCT02703532: Completed NA study, sponsored by Emory University.

NCT02703532 is a NA study that has completed, run by Emory University. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02703532, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target

Study Summary

The objective of this study is to identify the potential benefits of a home-based, intervention designed to facilitate carepartners' roles in stroke survivor rehabilitation. Stroke survivors and caregivers will participate in pairs. Stroke survivors will receive constraint induced movement therapy (CIMT). Caregivers of stroke survivors will be randomized to traditional caregiver education or a web based intervention for the duration of stroke survivor therapy. By learning the best way to involve family members in therapy, investigators hope to decrease the harmful effects of stroke.

Primary Outcome

Motor ability and impairments will be assessed using the Wolf Motor Function Test (WMFT) an assessment tool used to evaluate upper extremity performance while providing insight into joint-specific and total limb movements. Values represent the amount of time, in seconds, to complete the assessment. Lower scores (faster speed) are indicative of higher functioning levels.

Interventions

  • BEHAVIORAL Traditional Education
  • BEHAVIORAL CARE-CITE Education Program
  • BEHAVIORAL Constraint-Induced Movement Therapy (CIMT)

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2016-01
Est. Completion 2019-01-18
Phase NA
Emory University

1,208 total trials

What the finished NCT02703532 record still lists

NCT02703532 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 3 interventions - of which Traditional Education is the first listed.

NCT02703532 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02703532 about?

NCT02703532 is a clinical study titled "Evaluation of a CarePartner-Integrated Telehealth Rehabilitation Program for Persons With Stroke". The objective of this study is to identify the potential benefits of a home-based, intervention designed to facilitate carepartners' roles in stroke survivor rehabilitation. Stroke survivors and caregivers will participate in pairs. Stroke survivors will receive constraint induced movement therapy (...

What is the current status of trial NCT02703532?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2016-01. Estimated completion is 2019-01-18.

What interventions are being tested in trial NCT02703532?

The interventions under investigation include: Traditional Education (BEHAVIORAL), CARE-CITE Education Program (BEHAVIORAL), Constraint-Induced Movement Therapy (CIMT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02703532?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02703532's enrollment target sits among peer trials

64 1147th of 2000 higher than 844 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01853631 · 64 participants · Phase 1

    Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

  • NCT03739502 · 64 participants · Phase 2

    A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

  • NCT03739814 · 64 participants · Phase 2

    Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • NCT03866408 · 64 participants · Early Phase 1

    Insulin Regulation of Lipolysis and Lipolysis Proteins

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02703532, the US trial registry maintained by the National Library of Medicine. NCT02703532 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.